Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.60438 | 25 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.57247 | 25 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.57329 | 25 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.51332 | 24 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.50865 | 24 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.63378 | 24 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.61666 | 25 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.54336 | 24 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.52718 | 24 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.56137 | 25 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.55726 | 24 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.53758 | 24 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.56313 | 24 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.56278 | 24 |